Philip F Hughes (Philip Hughes)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Cancers

ACS chemical biology

Scientific reports

Science translational medicine

Duke University

Cornell University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Duke University Aug 10 2010

United States

Research Scientist :: Pharmacology and Cancer Biology

Education History

Cornell University Aug 20 1978 - May 15 1983

United States

PHD :: Chemistry

University of North Carolina at Chapel Hill Aug 20 1972 - May 04 1976

United States

BSC :: Chemistry

Publications

Robert Freeze, Kelly W Yang, Timothy Haystead, Philip F Hughes, Scott Scarneo
Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis. Pharmacology research & perspectives 11 (4) (2023)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Kensuke Kaneko, Hiroshi Nagata, Xiao-Yi Yang, Joshua D Ginzel, Zachary Hartman, Jeffrey I Everitt, Philip F Hughes, Timothy Haystead, Michael A Morse, Herbert Kim Lyerly, Takuya Osada
A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity. Cancers 14 (23) (2022)
Bushu Dong, Alex M Jaeger, Philip F Hughes, David R Loiselle, J Spencer Hauck, Yao Fu, Timothy A Haystead, Jiaoti Huang, Dennis J Thiele
Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1. Science translational medicine 12 (574) (2021)
Takuya Osada, Erika J Crosby, Kensuke Kaneko, Joshua C Snyder, Joshua D Ginzel, Chaitanya R Acharya, Xiao-Yi Yang, Thomas J Polascik, Ivan Spasojevic, Rendon C Nelson, Amy Hobeika, Zachary Conrad Hartman, Leonard M Neckers, André Rogatko, Philip F Hughes, Jiaoti Huang, Michael A Morse, Timothy Haystead, Herbert Kim Lyerly
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study. Molecular cancer therapeutics (2021)
Kensuke Kaneko, Takuya Osada, Michael A Morse, William R Gwin, Joshua D Ginzel, Joshua C Snyder, Xiao-Yi Yang, Cong-Xiao Liu, Marcio Augusto Diniz, Khaldon Bodoor, Philip F Hughes, Timothy Aj Haystead, Herbert Kim Lyerly
Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors. Communications biology 3 (1) (2020)
Scott A Scarneo, Antoine Mansourati, Liesl S Eibschutz, Juliane Totzke, Jose R Roques, David Loiselle, David A Carlson, Philip F Hughes, Timothy A J Haystead
Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion. Scientific reports 8 (1) (2018)
Lauren B Crowe, Philip F Hughes, David A Alcorta, Takuya Osada, Aaron P Smith, Juliane Totzke, David R Loiselle, Isaac D Lutz, Madhusudhana Gargesha, Debasish Roy, Jose Roques, David Darr, H Kim Lyerly, Neil L Spector, Timothy A J Haystead
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo. ACS chemical biology 12 (4) (2017)

Philip F Hughes.css-eqlu8i{font-size:small;padding-left:4px;} (Philip Hughes)

Publication Activity (10 Years)

Top Topics

Top Venues

Philip F Hughes (Philip Hughes)